Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famciclovir 1-Day vs Valacyclovir 3-Day for Recurrent Genital Herpes
NCT00306787Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of famciclovir in genital herpes (2 arms), sponsored by Novartis. Primary endpoint: Investigator-assessed Time to Healing of All Non-aborted Genital Herpes Lesions at Day 20. Started Mar 2006; status: completed.
02
Drugs
famciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00306787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306787.